Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Decreases By 33.3%

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a large decline in short interest in September. As of September 15th, there was short interest totaling 200 shares, a decline of 33.3% from the August 31st total of 300 shares. Based on an average daily volume of 1,700 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 1,700 shares, the short-interest ratio is currently 0.1 days.

BioSyent Price Performance

BIOYF opened at $8.45 on Tuesday. BioSyent has a 12-month low of $6.49 and a 12-month high of $8.85. The business’s fifty day simple moving average is $8.48 and its 200-day simple moving average is $8.27.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.